Bioprospecting for bioactives from seaweeds:Potential, obstacles and alternatives

Revista Brasileira de Farmacognosia

Volumn 22, Issue 4, 2012, Pages 894-905

  Pereira, Renato C ^a   Costa Lotufo, Leticia V ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Bioprospection; Marine natural products; Seaweeds

Indexed keywords

ANTIFOULING AGENT; BIOLOGICAL PRODUCT; CAULERPENIN; DICTYOPTERENE C; DITERPENE; ELATOL; EPITAONDIOL; FUCODIPHLORETHOL; FURANONE DERIVATIVE; HALIMEDATRIAL; LANOSOL; LOBOPHOROLIDE; PACHYDICTYOL A; POLYPHENOL; TERPENE; TERPENOID; UNCLASSIFIED DRUG; VIDALOL;

ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BIOPROSPECTION; BRAZIL; DRUG ACTIVITY; DRUG CYTOTOXICITY; HUMAN; NONHUMAN; REVIEW; SEAWEED;

EID: 84864004319     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2012005000077     Document Type: Review

References (131)

1. Aalbersberg B 1997. Biodiversity prospecting in the seas around Verata Tikina. http://www.worldwildlife.org/bsp/bcn/learning/ar97/97_fiji20.htm. Accessed in march 2011.
2. AIMS 2002. Annual report 2000-2001. AIMS (Australian Institute of Marine Sciences). http://www.aims.gov.au/pages/about/ar20002001/ar20002001-00.html.Accessed March 2011.
3. Aldridge S 2006. Marine bioprospecting for novel drugs. http://www.genengnews.com/articles/chitemaspx?aid=1958&chid=4. Accessed March 2011.
4. Amsler CD 2008. Algal chemical ecology. Berlin:Springer-Verlag.
5. Amsler CD, Moelber CB, McClintock JB, Iken KB, Baker BJ 2000. Chemical defenses against diatom fouling in Antarctic marine sponges. Biofouling 16: 29-45.
6. Barbosa JP, Fleury BG, Teixeira VL, Da Gama BAP, Pereira RC 2007. Natural products as antifoulants in a brazilian brown alga Dictyota pfaffii (Phaeophyta, Dictyotales). Biochem Syst Ecol 35: 549-553.
7. Beattie AJ, Hay M, Magnusson B, De Nys R, Meathers J, Vincent JFV 2010. Ecology and bioprospecting. Austral Ecol 36: 341-356.
8. Bernardi G, Springer GF 1962. Properties of highly purified fucan. J Biol Chem 237: 75-80.
9. Bhadury P, Wright PC 2004. Exploitation of marine algae: biogenic compounds for potential antifouling applications. Planta 219: 561-578.
10. Bianco EM, Rogers R, Teixeira VL, Pereira RC 2009. Antifoulant diterpenes produced by the brown seaweed Canistrocarpus cervicornis. J Appl Phycol 21: 341-346.
11. Blunt JW, Copp BR, Hu WP, Munro MHG, Northcote PT, Prinsep MR 2009. Marine natural products. Nat Prod Rep 26: 170-244.
12. Blunt JW, Copp BR, Munro MHG, Northcote PT, Prinsep MR 2011. Marine natural products. Nat Prod Rep 28: 196-268.
13. Bourgaud F, Gravot A, Milesi S, Gontier E 2001. Production of plant secondary metabolites: a historical perspective. Plant Sci 161: 839-851.
14. Bourgougnon N, Lahaye M, Quemener B, Chermann JC, Rimbert M, Cormaci M, Furnari G, Komprobst JM 1996. Annual variation in composition and in vitro anti-HIV-1 activity of the sulfated glucuronogalactan from Schizymenia dubyi (Rhodophyta, Gigartinales). J Appl Phycol 8: 155-161.
15. Brennan MR, Erickson KL 1978. Polyhalogenated indoles from the marine alga Rhodophyllis membranacea Harvey. Tetrahedron Lett 19: 1637-1640.
16. Bugni TS, Richards B, Bhoite L, Cimbora D, Harper MK, Ireland CM 2008a. Marine natural product libraries for high-throughput screening and rapid drug discovery. J Nat Prod 71: 1095-1098.
17. Bugni TS, Harper MK, McCulloch MWB, Reppart J, Ireland CM 2008b. Fractionated marine invertebrates extract libraries for drug discovery. Molecules 13: 1372-1383.
18. Butler AJ, Van Altena IA, Dunne SJ 1996. Antifouling activity of lyso-platelet-activating factor extracted from australian sponge Crella incrustans. J Chem Ecol 22: 2041-2061.
19. CBIN 2005. Marine and coastal biodiversity. CBIN (Canadian Biodiversity Information Network). http://www.cbin.ec.gc.ca/enjeux-issues/marine.cfm?lang=eng. Accessed in november 2011.
20. Chambers LD, Stokes KR, Walsh FC, Wood RJ K 2006. Modern approaches to marine antifouling coatings. Surf Coat Technol 201: 3642-3652.
21. Cragg GM, Newman DJ 2001. Natural product drug discovery in the next millennium. Pharm Biol 39: 8-17.
22. Cuevas C, Perez M, Martin MJ, Chicharro JL, Fernandez- Rivas C, Flores M, Francesch A, Gallego P, Zarzuelo M, de la Calle F, Garcia J, Polanco C, Rodriguez I, Manzanares I 2000. Synthesis of ecteinascidian ET- 743 and phthalascidin Pt-650 from cyanosafracin B. Org Lett 2: 2545-2548.
23. Da Gama BAP, Carvalho AGV, Weidner K, Soares AR, Coutinho R, Fleury BG, Teixeira VL, Pereira RC 2008. Antifouling activity of natural products from brazilian seaweeds. Bot Mar 51: 191-201.
24. Da Gama BAP, Pereira RC, Carvalho MGV, Coutinho R, Yoneshigue-Valentin Y 2002. The effects of seaweed secondary metabolites on biofouling. Biofouling 18:13-20.
25. Davidson SK, Allen SW, Lim GE, Anderson CM, Haygood MG 2001. Evidence for the biosynthesis of bryostatins by the bacterial symbiont ''Candidatus Endobugula sertula'' of the bryozoan Bugula neritina. Appl Environ Microb 67: 4531-4537.
26. Davis AR, Targett NM, McConnel OJ, Young CM 1989. Epibiosis of marine algae and benthic invertebrates: natural products chemistry and other mechanisms inhibiting settlement and overgrowth. Bioorg Mar Chem 3: 85-114.
27. Davyt D, Entz W, Fernandez R, Mariezcurrena R, Mombru AW, Saldana J, Dominguez L, Coll J, Manta E 1998. A new indole derivative from the red alga Chondria atropurpurea. Isolation, structure determination, and anthelmintic activity. J Nat Prod 61: 1560-1563.
28. De Nys R, Givskov M, Kumar N, Kjelleberg S, Steinberg PD 2006. Furanones. In: Fusetani N, Clare AS (org.). Antifouling compounds. Progress in Molecular and Subcellular Biology. Heidelberg: Springer, p. 55-86.
29. De Nys R, Wright AD, Konig GM, Sticher O 1993. New halogenated furanones from the marine alga Delisea pulchra (cf. fimbriata). Tetrahedron 49: 11213-11220.
30. Demunshi Y, Chugh A 2010. Role of traditional knowledge in marine bioprospecting. Biodivers Conserv 19: 3015-3033.
31. Dobretsov SV, Dahms HU, Qian PY 2005. Antibacterial and anti-diatom activity of Hong Kong sponges. Aquat Microb Ecol 38: 191-201.
32. Draget KI, Smidsrod O, Skjak-Braek G 2005. Alginates from algae. In: Steinbüchel A, Rhee SK (org). Polysaccharides and polyamides in food industry. properties, production, and patents. Weinheim: Willey-VCH Verlag GmbH & Co. p. 1-30.
33. Dworjanyn SA, De Nys R, Steinberg PD 1999. Localization and surface quantification of secondary metabolites in the red alga Delisea pulchra. Mar Biol 133: 727-736.
34. Faimali M, Sepcic K, Turk T, Geraci S 2003. Non-toxic antifouling activity of polymeric 3-alkylpyridinium salts from the Mediterranean sponge Reniera sarai Pulitzer-Finali. Biofouling 19: 47-56.
35. Fairhead VA, Amsler CD, McClintock JB, Baker BJ 2006. Lack of defense or phlorotannins induction by UV radiation or mesograzers in Desmarestia anceps and D. menziesii (Phaeophyceae). J Phycol 42: 1174-1183.
36. FAO 2003. Inland water resources and aquaculture service. Review of the state of world aquaculture. FAO Fisheries Circular. Rome: FAO.
37. Farias WRL, Valente AP, Pereira MS, Mourão PAS 2000. Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates. J Biol Chem 275: 29299-29307.
38. Farnsworth NR 1994. Ethnobotany and the search for new drugs. Chichester: Wiley.
39. Fusetani N 2004. Biofouling and antifouling. Nat Prod Rep 21: 94-104.
40. Fusetani N 2011. Antifouling marine natural products. Nat Prod Rep 28: 400-410.
41. Ganesan A 2001. Integrating natural product synthesis and combinatorial chemistry. Pure Appl Chem 73: 1033-1039.
42. Gerwick WH, Fenical W 1981. Ichthyotoxic and cytotoxic metabolites of the tropical brown alga, Stypopodium zonale. J Org Chem 46: 22-27.
43. Gleba D, Borisjuk NV, Borisjuk LG, Kneer R, Poulev A, Sarzhinskaya M, Dushenkov S, Logendra S, Gleba YY, Raskin I 1999. Use of plant roots for phytoremediation and molecular farming. P Natl Acad Sci USA 96: 5973-5977.
44. Gomez d'Ayala G, Malinconico M, Laurienzo P 2008. Marine derived polysaccharides for biomedical applications: chemical modification approaches. Molecules 13: 2069-2106.
45. Harbor Branch Media Lab Project 2008. ''Drugs from the sea'' index. http://www.marinebiotech.org/dfsindex_alpha.html. Accessed in march 2011.
46. Harder T, Dobretsov S, Qian PY 2004.Waterborne polar macromolecules act as algal antifoulants in the seaweed Ulva reticulata. Mar Ecol-Prog Ser 274: 133-141.
47. Harper MK, Bugni TS, Copp BR, James RD, Lindsay BS, Richardson AD, Schnabel PC, Tasdemir D, VanWagoner RM, Verbitski SM, Ireland CM 2001. Introduction to the chemical ecology of marine natural products. In: McClintock JB, Baker BJ (org.). Marine chemical ecology. 1. ed. Boca Raton: CRC Press, p. 3-79.
48. Hart JB, Lill RE, Hickford SJH, Blunt JW, Munro MHG 2000. The halichondrins: chemistry, biology, supply and delivery. In: Fusetani N (org.). Drugs from the sea. Basel: Karger, p. 134-154.
49. Harvey A 2000. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 5: 294-300.
50. Hay ME, Fenical W 1988. Marine plant-herbivore interactions: the ecology of chemical defense. Annu Rev Ecol Syst 19: 111-145.
51. Hayashi L, Yokoya NS, Kikuchi DM, Oliveira EC 2008. Callus induction and micropropagation improved by colchicine and phytoregulators in Kappaphycus alvarezii (Rhodophyta, Solieriaceae). J Appl Phycol 20: 653-659.
52. Hellio C, Bremer G, Pons Am, Le Gal Y, Bourgougnon N 2000. Inhibition of the development of microorganisms (bacteria and fungi) by extracts of marine algae from Britanny, France. Appl Microbiol Biot 54: 543-549.
53. Hellio C, Thomas-Guyon H, Culioli G, Piovetti L, Bourgougnon N, Le Gal Y 2001. Marine antifoulants from Bifurcaria bifurcata (Phaephyceae, Cystoseiraceae) and other brown macroalgae. Biofouling 17: 189-201.
54. Hellio C, Yebra D 2009. Advances in marine antifouling coatings and technologies. Cambridge: Woodhead Publishing Limited.
55. Heo SJ, Park PJ, Park EJ, Kim SK, Jeon YJ 2005. Antioxidantactivity of enzymatic extracts from a brown seaweed Ecklonia cava by electron spin resonance spectrometry and comet assay. Eur Food Res Technol 221: 41-47.
56. Hidari KIPJ, Takahashi N, Arihara M, Nagaoka M, Morita K, Suzuki T 2008. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Bioph Res Co 376: 91-95.
57. Hill RT, Fenical W 2010. Pharmaceuticals from marine natural products: surge or ebb? Curr Opin Biotech 21:777-779.
58. Hu GP, Yuan J, Sun L, She ZG, Wu JH, Lan XJ, Zhu X, Lin YG, Chen SP 2011. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs 9: 514-525.
59. Hunt B, Vincent ACJ 2006. Scale and sustainability of marine bioprospecting for pharmaceuticals. Ambio 35: 57-64.
60. Imhoff JF, Labes A, Wiese J 2011. Bio-mining the microbial treasures of the ocean: new natural products. Biotechnol Adv 29: 468-482.
61. Ireland CM, Copp BR, Foster MP, McDonald LA, Radisky DC, Swersey JC 1993. Biomedical potential of marine natural products. In: Attaway DH, Zaborsky OR (org.). Marine Biotechnology. New York: Plenum Press, p. 1-43.
62. Jensen PR, Fenical W 2000. Marine microorganisms and drug discovery: current status and future potential. In: Fusetani N (Ed). Drugs from the sea. Basel: Karger, p. 6-29.
63. Jiao G, Yu G, Zhang J, Ewart HE 2011. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar Drugs 9: 196-223.
64. Katz L, McDaniel R 1999. Novel macrolides through genetic engineering. Med Res Rev 19: 543-558.
65. Kelly SR, Jensen PR, Henkel TP, Fenical W, Pawlik JR 2003. Effects of Caribbean sponge extracts on bacterial attachment. Aquat Microb Ecol 31: 175-182.
66. Kelman D, Kushmaro A, Loya Y, Kashman Y, Benayashu Y 1998. Antimicrobial activity of a Red Sea soft coral, Parerythropodium fulvum fulvum: reproductive and developmental considerations. Mar Ecol-Prog Ser 169: 87-95.
67. Khan MNA, Suk-Choi J, Lee MC, Kim E, Nam TJ, Fujii H, Hong YK 2008. Anti-inflammatory activities of methanol extracts from various seaweed species. J Environ Biol 29: 465-469.
68. Koh LL, Tan TK, Chou LM, Goh NKC 2002. Antifungal properties of Singapore gorgonians: a preliminary study. J Exp Mar Biol Ecol 273: 121-130.
69. Konig GM, Wright AD 1997. Laurencia rigida: chemical investigations of its antifouling dichloromethane extract. J Nat Prod 60: 967-970.
70. Konig GM, Wright AD, de Nys R 1999. Halogenated monoterpenes from Plocamium costatum and their biological activity. J Nat Prod 62: 383-385.
71. Kubanek J, Jensen PR, Keifer PA, Sullards C, Collins DO, Fenical W 2003. Seaweed resistance to microbial attack: A targeted chemical defense against marine fungi. P Natl Acad Sci USA 100: 6916-6921.
72. Kursar TA, Caballero-George CC, Capson TL, Cubilla-Rios L, Gerwick WH, Gupta MP, Ibaňes A, Linington RG, Mcphai KL, Ortegabarria E, Romero LI, Solis PN, Cole PD 2007. Securing economic benefits and promotion conservation through bioprospecting. Bioscience 56: 1005-1012.
73. Lahaye M 2001. Developments on gelling algal galactans, their structure and physico-chemistry. J Appl Phycol 13: 173-184.
74. Lane AL, Moore BS 2011. A sea of biosysnthesis: marine natural products meet the molecular age. Nat Prod Rep 28: 411-428.
75. Lattmann E, Billington DC, Langley CA 1999. Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)- furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanones. Drug Des Discovery 16: 237-242.
76. Lau SCK, Qian PY 1997. Phlorotannins and related compounds as larval settlement inhibitors of the tubebuilding polychaete Hydroides elegans. Mar Ecol-Prog Ser 159: 219-227.
77. Laurienzo P 2010. Marine polysaccharides in pharmaceutical applications: an overview. Mar Drugs 8: 2435-2465.
78. Li Z, He L, Miao X 2007. Cultivable bacterial community from south China sea sponge as revealed by DGGE fingerprinting and 16S rDNA phylogenetic analysis. Curr Microbiol 55: 465-472.
79. Lincoln RA, Strupinski K, Walker JM 1991. Bioactive compounds from algae. Life Chem Rep 8: 97-183.
80. Lopanik N, Lindquist N, Targett N 2004. Potent cytotoxins produced by a microbial symbiont protect host larvae from predation. Oecologia 139: 131-139.
81. Lopez-Macia A, Jimenez JC, Royo M, Giralt E, Alberico F 2001. Synthesis and structure determination of Kahalalide F. J Am Chem Soc 123: 11398-11401.
82. Lüning K, Pang S 2003. Mass cultivation of seaweeds: current aspects and approaches J Appl Phycol 15: 115-119.
83. Maschek JA, Baker BJ 2008. The chemistry of algal secondary metabolism. In: Amsler CD (org.). Algal chemical ecology. Berlin: Springer-Verlag. p. 1-24.
84. Mayer AMS, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE 2010. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 31: 255-265.
85. McDaniel R, Ebert-Khosla S, Hopwood DA, Khosla C 1995. Rational design of aromatic polyketide natural products by recombinant assembly of enzymatic subunits. Nature 375: 548-554.
86. Mendola D 2000. Aquacultural production of bryostatin 1 and Ecteinascidian 743. In: Fusetani N (org.). Drugs from the sea. Basel:Karger, p. 120-133.
87. Mendola D 2003. Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: process developments and economics. Biomol Eng 20: 441-458.
88. Molinski TF 2010. Microscale methodology for structure elucidation of natural products. Curr Opin Biotech 21: 819-826.
89. Molinski TF, Dalisay, DS, Lievens SL, Saludes JP 2009. Drug development from marine natural products. Nat Rev Drug Discov 28: 69-85.
90. Munro MHG, Blunt JW, Dumdei EJ, Hickford SJH, Lill RE, Li S, Battershill CN, Duckworth AR 1999. The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol 70: 15-25.
91. Muscholl-Silberhorn A, Thiel V, Imhoff JF 2007. Abundance and bioactivity of cultured sponge-associated bacteria from the Mediterranean Sea. Microb Ecol 55: 94-106.
92. Newman DJ, Cragg GM 2004. Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod 67: 1216-1238.
93. Nuijen B, Bouma M, Talsma H, Manada C, Jimeno JM, Lopez- Lazaro L, Bult A, Beijnen JH 2000. Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F. Drug Dev Ind Pharm 27: 767-780.
94. Palermo JA, Flower BP, Seldes AM 1992. Chondriamides A and B new indolic metabolities from red algae Chondria sp. Tetrahedron Lett 33: 3097-3100.
95. Pavia H, Brock E 2000. Extrinsic factors influencing phlorotannin production in the brown alga Ascophyllum nodosum. Mar Ecol-Prog Ser 193: 285-294.
96. Pomin VH, Mourão PA 2008. Structure, biology, evolution, and medical importance of sulfated fucans and galatans. Glycobiology 12: 1016-1027.
97. Pomponi SA 1999. The bioprocess-technological potential of the sea. J Biotechnol 70: 5-13.
98. Proksch P, Edrada-Ebel R, Ebel R 2003. Drugs from the seaopportunities and obstacles. Mar Drugs 1: 5-17.
99. Qian PY, Xu Y, Fusetani N 2010. Natural products as antifouling compounds: recent progress and future perspectives. Biofouling 26: 223-234.
100. Ramalingam JR, Kaliaperumal N, Kalimuthu, S. 2003. Commercial scale production of production of carrageenan from red algae. Seaweed Res Utiln 25:37-46.
101. Reani A, Cosson J, Parker A 1998. Seasonal variation of growth, carrageenan content and rheological properties of Eytoclonium purpureum (Huds.). Bot Mar 41: 383-387.
102. Rinehart K, Holt TG, Fregeau NL, Stroh JG, Kiefer PA, Sun F, Li L, Martin DG 1990. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J Org Chem 55: 4512-4515.
103. Rittschof D 2000. Natural product antifoulants: one perspective on the challenges related to coatings development. Biofouling 15: 119-127.
104. Rouhi AM 2003. Moving beyond natural products. Chem Eng News 81: 104-107.
105. Sera Y, Adachi K, Shizuri Y 1999. A new epidioxy sterol as an antifouling substance from a Palauan marine sponge, Lendenfeldia chondrodes. J Nat Prod 62: 152-154.
106. Shibata T, Fujimoto K, Nagayama K, Yamaguchi K, Nakamura T 2002. Inhibitory activity of brown algal phlorotannins against hyaluronidase. Int J Food Sci Tech 37: 703-709.
107. Smit AJ 2004. Medicinal and pharmaceutical uses of seaweed natural products: a review. J Appl Phycol 16: 245-262.
108. Sousa APA, Torres MR, Pessoa C, Moraes MO, Rocha-Filho FD, Alves APNN, Costa-Lotufo LV 2007. In vivo growth-inhibition of sarcoma 180 tumor by alginates from brown seaweed Sargassum vulgare. Carbohyd Polym 69: 7-13.
109. Sparidans RW, Stokvis E, Jimeno JM, Lopez-Lazaro L, Schellens JH, Beijnen JH 2001. Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anticancer agent kahalalide F. Anti-Cancer Drug 12: 575-582.
110. Stafford AM, Pazoles CJ, Siegel S, Yeh L-A 1998. Plant cell culture: a vehicle for drug discovery. In: Harvey AL (org.). Advances in drug techniques. New York: John Wiley & Sons, p. 53-64.
111. Steinberg PD 1992. Geographical variation in the interaction between marine herbivores and brown algal secondary metabolites. In: Paul VJ (org.). Ecological roles of marine natural products. 1. ed. New York: Comstock Publishing Associates, p. 51-91.
112. Steinberg PD, de Nys R, Kjelleberg S 2001. Chemical mediation of surface colonization. In: McClintock JB, Baker BJ (org.). Marine chemical ecology. 1. ed. Boca Raton: CRC Press, p. 355-387.
113. Sudatti DB, Fujii MT, Rodrigues SV, Turra A, Pereira RC 2011. Effect of abiotic factors on growth and chemical defense content in Laurencia dendroidea J. Agardh (Ceramiales, Rhodophyta) cultivated clones. Mar Biol 158: 1439-1446.
114. Sudatti DB, Rodrigues SV, Pereira RC 2006. Quantitative GC-ECD analysis of halogenated metabolites: determination of elatol on surface and within-thallus of Laurencia obtusa. J Chem Ecol 32: 835-843.
115. Sukarmi S, Sabdono A 2008. Ethical perspectives of sustainable use of reef́s invertebrates as a source of marine natural products. J Coastal Dev 11: 97-103.
116. Takada N, Watanabe R, Suenga K, Yamada K, Ueda K, Kita M, Uemura D 2001. Zamamistatin, a significant antibacterial bromotyrosine derivative, from the Okinawa sponge Pseudoceratina purpurea. Tatrahedron Lett 42: 5265-5267.
117. Takahashi S, Matsunaga T, Hasegawa C, Saito H, Fujita D, Kiuchi F, Tsuda Y 1997. Studies on bioactive substances in natural resources. Toyama-ken Yakuji Kenkyusho Nenpo 24: 53-57.
118. Takamatsu S, Hodges TW, Rajbhandari I, Gerwick WH, Hamann MT, Nagle DG 2003. Marine natural products as novel antioxidant prototypes. J Nat Prod 66: 605-608.
119. Tharkur NL, Jain R, Natalio F, Hamer B, Thakur AN, Müller WEG 2008. Marine molecular biology: an emerging field of biological sciences. Biotechnol Adv 26: 233-245.
120. The Treaty of Waitangi 2006. What the treaty says. http://www.immigration.govt.nz/migrant/settlementpack/treaty/WhatTheTreatySays/. Accessed in march 2011.
121. Thomas TRA, Kavlekar DP, LokaBharathi PA 2010. Marine drugs from sponge-microbe association-a review. Mar Drugs 8: 1417-1468.
122. Tittensor DP, Mora C, Jetz W, Lotze HK, Ricard D, Berghe EV, Worm B 2010. Global patterns and predictors of marine biodiversity across taxa. Nature 466: 1098-1103.
123. Toth GB, Pavia H 2006. Artificial wounding decreases plant biomass and shoot strength of the brown seaweed Ascophyllum nodosum (Fucales, Phaeophyceae). Mar Biol 148: 1193-1199.
124. Trindade-Silva AE, Lim-Fong GE, Sharp KH, Haygood MG 2010. Bryostatins: biological context and biotechnological prospects. Curr Opin Biotech 21:834-842.
125. Vairappan CS, Suzuki M, Abe T, Masuda M 2001. Halogenated metabolites with antibacterial activity from the Okinawan Laurencia species. Phytochemistry 58: 517-523.
126. Vallinayagam K, Arumugam R, Ragupathi RKR, Thirumaran G, Anantharaman P 2009. Antibacterial activity of some selected seaweeds from Pudumadam coastal regions. Global J Pharmacol 3: 50-52.
127. Veiga-Santos P, Pelizzaro-Rocha KJ, Santos AO, Ueda-Nakamura T, Dias-Filho BP, Silva SO, Sudatti DB, Bianco EM, Pereira RC, Nakamura CV 2010. In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea. Parasitology 137:1661-1670.
128. Vo TS, Kim SK 2010. Potential Anti-HIV agents from marine resources: an overview. Mar Drugs 8: 2871-2892.
129. Waters AL, Hill RT, Place AR, Hamann MT 2010. The expanding role of marine microbes in pharmaceutical development. Curr Opin Biotech 21: 780-786.
130. White DE, Stewart IC, Grubbs RH, Stoltz BM 2008. The catalytic asymmetric total synthesis of elatol. J Am Chem Soc 130: 810-811.
131. Yuan H, Song J, Li X, Li N, Dai J 2006. Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides. Cancer Lett 243: 228-234.